Journal
Pharmacological Reports
Pharmacological Reports is focusing on recent developments in experimental and clinical pharmacology.
Gliomas are the most prevalent malignant primary brain tumors and one of the deadliest cancers in humans. Despite multimodal therapies, the prognosis of glioma patients remains poor, with a median survival of about one year for glioblastoma, the most aggressive glioma. Expanding the knowledge of the mechanisms underlying glioma pathobiology and exploring new therapeutic options is crucial to improving survival rates.
The aim of this Special Issue is to collect research articles and review manuscripts that present recent advances in the understanding of glioma development and progression, as well as breakthroughs in glioma therapies. Particular topics of interest include, but are not limited to, the identification of molecular targets, novel drug candidates, and innovative treatment approaches.
Guest editor: Monika Szeliga, PhD
Department of Neurotoxicology
Mossakowski Medical Research Institute, Polish Academy of Sciences
Pawińskiego 5, Warszawa, Poland
Submission Information
Manuscript submission date: 31 December, 2025
Please refer to the Submission guidelines to prepare your manuscript, and select the Special Issue "Novel drug targets and therapeutic approaches in glioma” when submitting your paper online at the journal’s submission platform.
Keywords: glioma, molecular mechanism, molecular target, drug candidate, treatment.
Contact details:
Katarzyna Fijał
Deputy Editor-in-Chief
Pharmacological Reports
Submit your manuscript to this collection through the participating journal.
-
Monika Szeliga, PhD
Monika Szeliga graduated from the Warsaw University (Faculty of Biology) and began working at the Institute of Mother and Child in Warsaw. She then moved to the Mossakowski Medical Research Institute, Polish Academy of Sciences (MMRI PAS), where she received a Ph.D. in medical sciences. During her PhD studies, she focused on the role of glutaminase in shaping the phenotype of gliomas. The biology of these tumors and the search for new therapeutic strategies currently remain her main research interests.